News and Trends 20 Aug 2019
Nabriva Therapeutics Gets FDA Green Light for Pneumonia Antibiotic
The US FDA has approved Nabriva Therapeutics’ Xenleta for treating community-acquired bacterial pneumonia, the first in a new class of antibiotics developed to treat this condition. Xenleta, also known as…